Scientists Having Hard Time Keeping Track Of Patients Who Have Undergone Gene-Editing Treatments In China

According to the Wall Street Journal, a number of cancer patients in China underwent gene modification with the gene-editing tool, CRISPR-Cas9, but some scientists who administered the trial have neglected to keep track of patients who underwent gene-editing treatment.